PG Versus TG for Advanced PGC

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

96 participants

Study Classification

INTERVENTIONAL

Study Start Date

2024-09-04

Study Completion Date

2025-09-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

We conducted a retrospective study on patients with pathological stage II-III PGC who underwent PG or TG from 2013 to 2023. Propensity score-matching was applied to adjust for tumor size and stage between the PG and TG groups at a 1:1 ratio. We evaluated the procedural safety, oncological, and functional outcomes.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Minimal Invasive Surgery for Gastric Subepithelial Tumor

NCT05452265

Gastric Subepithelial Tumor

COMPLETED

Analysis of Tumor Deposit at the Fusion Site of the Right Gastric Mesentery and Left Gastric Mesentery in the Patients With Gastric Cancer Who Received Proximal Gastrectomy

NCT06728891

Gastric Carcinoma

RECRUITING

Endoscopic Submucosal Dissection Versus Gastrectomy

NCT02216110

Early Gastric Cancer

COMPLETED

ICG-NIR Guided Lymph Node Dissection in Gastric Cancer

NCT04056260

Stomach Neoplasm

UNKNOWN NA

Laparoscopic Proximal Gastrectomy With Double-flap Technique Versus Laparoscopic Total Gastrectomy With Roux-en-Y Reconstruction for Proximal Early Gastric Cancer

NCT05890339

Stomach Neoplasms

NOT_YET_RECRUITING NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Gastric Adenocarcinoma Gastrectomy

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

FACTORIAL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Proximal gastrectomy

Group Type EXPERIMENTAL

proximal gastrectomy

Intervention Type PROCEDURE

proximal gastrectomy

Total gastrectomy

Group Type ACTIVE_COMPARATOR

total gastrectomy

Intervention Type PROCEDURE

total gastrectomy

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

proximal gastrectomy

Intervention Type PROCEDURE

total gastrectomy

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Proximal gastric adenocarcinoma after total or proximal gastrectomy.

Exclusion Criteria

* Non-curative resections
* Non-adenocarcinoma histology
* Distally located tumors or middle/proximally located tumors for which distal margin could not be secured by PG
* Remnant gastric cancer
* Clinically T1N0 tumors smaller than 3 cm for which PG was clearly indicated

Minimum Eligible Age

20 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No